कृपया अन्य खोज का प्रयास करें
Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapeutics for Parkinson’s disease and related disorders. Its lead product candidate is IkT-148009, a non-receptor Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson’s disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia. Inhibikase Therapeutics, Inc. has research and development collaborations with Johns Hopkins University, Arizona State University, and Michigan State University; and a collaborative research and development agreement with Sphaera Pharma Pte. Ltd. The company was founded in 2008 and is headquartered in Atlanta, Georgia.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Milton H. Werner | 59 | 2010 | CEO, President & Director |
Roy Lester Freeman | 70 | 2020 | Independent Director |
Valina L. Dawson | - | - | Member of Scientific Advisory Board |
Gisele Dion | 56 | 2022 | Independent Director |
Charles Warren Olanow | - | - | CEO of Clintrex Research Corporation & Member of Scientific Advisory Board |
Paul C. Grint | 65 | 2020 | Independent Director |
Karl Kieburtz | - | - | Member of Scientific Advisory Board |
Jeffrey H. Kordower | - | - | Member of Scientific Advisory Board |
Kenneth L. Marek | - | - | Member of Scientific Advisory Board |
Pankaj Jay Pasricha | - | - | Member of Scientific Advisory Board |
Robert A. Hauser | - | - | Member of Scientific Advisory Board |
Dennis N. Berman | 72 | 2020 | Independent Director |
Ted M. Dawson | - | - | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है